CAPSONI, SIMONA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 10.191
EU - Europa 9.146
AS - Asia 2.547
SA - Sud America 353
Continente sconosciuto - Info sul continente non disponibili 49
AF - Africa 22
OC - Oceania 5
Totale 22.313
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 10.140
IT - Italia 2.854
SE - Svezia 1.601
IE - Irlanda 1.248
RU - Federazione Russa 1.018
SG - Singapore 986
DE - Germania 750
TR - Turchia 686
CN - Cina 619
UA - Ucraina 604
GB - Regno Unito 359
BR - Brasile 320
FI - Finlandia 272
CH - Svizzera 129
AT - Austria 98
IL - Israele 60
BE - Belgio 54
EU - Europa 47
CA - Canada 44
VN - Vietnam 42
FR - Francia 37
NL - Olanda 29
AL - Albania 22
ID - Indonesia 20
JP - Giappone 20
KR - Corea 13
IQ - Iraq 11
AE - Emirati Arabi Uniti 9
AR - Argentina 9
ES - Italia 9
HK - Hong Kong 9
IN - India 9
BD - Bangladesh 8
PK - Pakistan 8
DK - Danimarca 7
PL - Polonia 7
UZ - Uzbekistan 7
CZ - Repubblica Ceca 6
EC - Ecuador 6
HU - Ungheria 6
RS - Serbia 6
ZA - Sudafrica 6
LT - Lituania 5
MA - Marocco 5
VE - Venezuela 5
AU - Australia 4
BG - Bulgaria 4
CL - Cile 4
EG - Egitto 4
LU - Lussemburgo 4
MX - Messico 4
BN - Brunei Darussalam 3
IR - Iran 3
JO - Giordania 3
PT - Portogallo 3
PY - Paraguay 3
TH - Thailandia 3
TW - Taiwan 3
A2 - ???statistics.table.value.countryCode.A2??? 2
AM - Armenia 2
BH - Bahrain 2
GR - Grecia 2
IM - Isola di Man 2
KE - Kenya 2
KG - Kirghizistan 2
KW - Kuwait 2
KZ - Kazakistan 2
LA - Repubblica Popolare Democratica del Laos 2
LI - Liechtenstein 2
MD - Moldavia 2
MN - Mongolia 2
MT - Malta 2
OM - Oman 2
PE - Perù 2
PH - Filippine 2
RO - Romania 2
TN - Tunisia 2
UY - Uruguay 2
AZ - Azerbaigian 1
BO - Bolivia 1
CO - Colombia 1
DO - Repubblica Dominicana 1
DZ - Algeria 1
JM - Giamaica 1
LK - Sri Lanka 1
MK - Macedonia 1
MM - Myanmar 1
MO - Macao, regione amministrativa speciale della Cina 1
NG - Nigeria 1
NO - Norvegia 1
NP - Nepal 1
NZ - Nuova Zelanda 1
PA - Panama 1
PS - Palestinian Territory 1
SA - Arabia Saudita 1
SC - Seychelles 1
Totale 22.313
Salva come PNG Salva come JPEG
Città #
Pisa 2.049
Chandler 1.373
Jacksonville 1.300
Dublin 1.246
Boardman 854
Izmir 530
Wilmington 526
Ashburn 512
Singapore 427
Ann Arbor 399
Moscow 293
Boston 285
Millbury 264
Düsseldorf 227
The Dalles 223
Mestre 188
San Mateo 181
New York 157
Istanbul 148
Munich 122
Ogden 121
Bremen 119
Seattle 109
Bern 107
Princeton 106
Washington 93
Helsinki 92
Lawrence 91
Woodbridge 88
Vienna 87
Beijing 81
San Paolo di Civitate 67
Milan 64
Saint Petersburg 63
Guangzhou 54
Dearborn 53
Holon 51
North Bergen 51
Brussels 50
Shanghai 49
Dong Ket 39
Rome 39
Scuola 38
Los Angeles 37
Santa Clara 33
Wuhan 33
Toronto 30
San Giuliano Terme 28
Fairfield 26
Council Bluffs 24
Hefei 24
Norwalk 23
Chicago 21
Nanjing 21
Jakarta 20
Houston 19
Las Vegas 19
Bientina 16
Florence 16
Jiaxing 16
Edinburgh 15
Frankfurt am Main 15
Tokyo 15
Andover 14
Kunming 14
São Paulo 14
Berlin 13
Shenzhen 13
Padova 12
San Diego 12
Wuxi 12
London 11
Cambridge 10
Lausanne 10
Paris 10
Cesano Boscone 9
Falls Church 9
Ferrara 9
Jinan 9
Livorno 9
Nuremberg 9
Zurich 9
Amsterdam 8
Belo Horizonte 8
Brasília 8
Rio de Janeiro 8
Stockholm 8
Tappahannock 8
Voghera 8
Auburn Hills 7
Hong Kong 7
Seoul 7
Tashkent 7
Verona 7
Yiwu 7
Betim 6
Budapest 6
Cusano Milanino 6
Graz 6
Nanchang 6
Totale 13.803
Salva come PNG Salva come JPEG
Nome #
Initial events leading to ß amyloid expression in anti-NGF transgenic mice. 2.425
The contribution of early inflammation to neurodegeneration in anti-Nerve Growth Factor mice 284
Enteric Alpha-synuclein inclusions, colonic inflammation, increased mucosal permeability and alterations of Bowel neuromuscular functiond precede central neurodegeneration in a transgenic mouse model of Parkinson's disease 192
The chemokine CXCL12 mediates the anti-amyloidogenic action of painless human nerve growth factor 189
Intranasal "painless" Human Nerve Growth Factors Slows Amyloid Neurodegeneration and Prevents Memory Deficits in App X PS1 Mice 189
2-Bromomelatonin: synthesis and characterization of a potent melatonin agonist 187
(2008) Receptor for Advanced Glycation End Product-Dependent Activation of p38 Mitogen-Activated Protein Kinase Contributes to Amyloid-ß-Mediated Cortical Synaptic Dysfunction 183
Graphene promotes axon elongation through local stall of Nerve Growth Factor signaling endosomes 182
Toxic properties of microsome-associated alpha-synuclein species in mouse primary neurons 176
A new mechanism for Alzheimer neurodegeneration: functional antagonism between proNGF, mature NGF and their receptors 172
Congenital pain insensitivity mutation in nerve growth factor gene uncouples nociception from central features of pain in heterozygous humans and mice 162
NGF steers microglia toward a neuroprotective phenotype 160
The positional identity of mouse ES cell-generated neurons is affected by BMP signaling. 159
COMPOSIZIONI IN GRADO DI PREVENIRE EVENTI NEURODEGENERATIVI E METODO PER SAGGIARNE L'ATTIVITA' 159
Enteric alpha-synuclein accumulation impairs intestinal epithelial barrier through inflammasome activation before the onset of brain pathology in a transgenic mouse model of Parkinson's disease 154
The NGFR100W Mutation Specifically Impairs Nociception without Affecting Cognitive Performance in a Mouse Model of Hereditary Sensory and Autonomic Neuropathy Type V 151
ProNGF/NGF inbalance triggers neurodegeneration in transgenic mice. 150
ANIMALI TRANSGENICI NON UMANI ANTI-NGF 146
Identification of proNGF versus NGF expression fingerprinting in PC12 cells 140
A dual mechanism linking NGF/proNGF imbalance and early inflammation to Alzheimer's disease neurodegeneration in the AD11 anti-NGF mouse model 139
Amyloid plaque-independent deficit of early postnatal visual cortical plasticity in the 5xFAD transgenic model of Alzheimer's disease. 137
Role of NGF in modulating adult neurogenesis in ALzheimer's disease mouse model 136
Over-expression of furin-resistant pro-NGF determines neurodegeneration in transgenic mice 135
A new generation of NGF-based therapy for Alzheimer’s disease 134
A carnivore species (Canis familiaris) expresses circadian melatonin rhythm in the peripheral blood and melatonin receptors in the brain 134
Pathogen Free Conditions Slow the Onset of Neurodegeneration in a Mouse Model of Nerve Growth Factor Deprivation 132
Intranasal administration of a painless human NGF reduces memory deficit and amyloid oligomers accumulation in APPxPS1 mice 132
Environmental enrichment prevents the onset of memory deficits and reduces neuropathological hallmarks in a mouse model of Alzheimer-like neurodegeneration 131
Nerve Growth Factor regulates astrocyte physiology in vivo 131
Acute cholinergic rescue of synaptic plasticity in the neurodegenerating cortex of anti-nerve-growth-factor mice 130
The role of Nerve Growth Factor in development and in ALzheimer's disease 129
null 129
Alzheimer-like neurodegeneration in aged anti-nerve growth factor mice 128
ProNGFNGF imbalance triggers learning and memory deficits, neurodegeneration and spontaneous epileptic-like discharges in transgenic mice 127
Intranasal administration of an optimized human Nerve Growth Factor reduces memory deficits and amyloid oligomers accumulation in APPxPS1 mice 127
Abeta (1-42) impairs LTP in mous eneocortex through RAGE mediated activation of p38 MAP kinase 125
Effects of cholinesterase inhibitor galantamine in a mouse model of Alzheimer disease, the anti-NGF AD11 mice 125
Involvement of NGF in early stages of chick embryo development 124
COMPOSITIONS ABLE TO PREVENT NEURODEGENERATIVE PROCESSES AND METHODS OF ASSAYING THE SAME 124
Gene expression biomarkers in the brain of a mouse model for Alzheimer's disease: mining of microarray data by logic classification and feature selection 123
MUTEINS OF HNGF, THERAPEUTIC USES AND PHARMACEUTICAL COMPOSITIONS 123
Effects of the cholinesterase inhibitor galantamine in a mouse model of Alzheimer's disease, the anti-nerve growth factor AD11 transgenic mice 123
Alzheimer-like neurodegeneration in anti-Nerve Growth Factor transgenic mice 122
Memoquin: A new therapeutic poly-agent for Alzheimer's disease 121
Localization and characterization of melatonin binding sites in the brain of the rabbit (Oryctolagus cuniculus) by autoradiography and in vitro ligand-receptor binding 121
Functional Characterization of Human ProNGF and NGF Mutants: Identification of NGF P61SR100E as a "Painless" Lead Investigational Candidate for Therapeutic Applications 121
A new generation of non invasive NGF-based therapies for Alzheimer’s Disease 120
Morphological basis for pineal secretion in domestic Ungulata 120
Ganstigmine and donepezil improve neurodegeneration in AD11 antinerve growth factor transgenic mice 119
Alzheimer-like neurodegeneration in aged antinerve growth factor transgenic mice 119
NON-HUMAN TRANSGENIC ANIMALS FOR THE STUDY OF NEURODEGENERATIVE SYNDROMES 118
Alzheimer-like neurodegeneration in aged anti-Nerve Growth Factor (NGF) mice 118
Failure of nicotine-dependent enhancement of synaptic efficacy at Schaffer-collateral CA1 synapses of AD11 anti-nerve growth factor transgenic mice 117
Cholinesterase inhibitors with nicotinic mode of action: Neuroprotection in anti-NGF mice 117
Intranasal delivery of therapeutic proteins for neurological diseases 117
A small molecule targeting the multifactorial nature of Alzheimer's disease 117
Autoradiographic localization of putative melatonin receptors in the brains of two old world primates: Cercopithecus aethiops and Papio ursinus 116
Inflammatory responses in anti-Nerve Growth Factor transgenic mice 116
An unbalance of proNGF/NGF signalling determines AD-like neurodegeneration in mice. 116
NON HUMAN TRANSGENIC ANIMAL AS A MODEL OF NEURODEGENERATIVE DISEASES AND FOR THE EARLY DIAGNOSIS THEREOF 114
Role of NGF in modulating adult neurogenesis in an Alzheimer's disease mouse model 113
On the molecular basis linking Nerve Growth Factor (NGF) to Alzheimer’s disease 113
Transgenic mouse models of neurotrophin function and effects on amyloid plaques and neurofibrillary pathology 112
Neutralization of nerve growth factor impairs proliferation and differentiation of adult neural progenitors in the subventricular zone 112
Autoradiographic quantification of endothelin ET(A)receptors in peripheral and brain arteries of the rat 111
IN VITRO RECEPTOR BINDING PROPERTIES OF A "PAINLESS" NGF MUTEIN, LINKED TO HEREDITARY SENSORY AUTONOMIC NEUROPATHY TYPE V 110
Amelioration of the neurodegenerative phenotype in AD11 anti-NGF mice 110
Taking pain out of NGF: a "painless" NGF mutant, linked to hereditary sensory autonomic neuropathy type V, with full neurotrophic activity. 110
From genes to pain: nerve growth factor and hereditary sensory and autonomic neuropathy type V 109
Enteric α-synuclein impairs intestinal epithelial barrier through caspase-1-inflammasome signaling in Parkinson's disease before brain pathology 109
ANIMALI TRANSGENICI NON UMANI ESPRIMENTI ANTICORPI ANTI-NGF. 108
NON-HUMAN TRANSGENIC ANIMALS FOR THE STUDY OF NEURODEGENERATIVE SYNDROMES 108
Long-term memantine treatment prevents behavioral deficits in a mouse model of sporadic Alzheimer's disease 108
Nerve Growth Factor and galantamine ameliorate early signs of neurodegeneration in anti-nerve growth factor mice 107
Development of a non-invasive NGF-based therapy for Alzheimer's disease. Current Alzheimer Research 6: 158 107
Long-term memantine treatment prevents behaviour deficits in a mouse model of sporadic Alzheimer's disease 106
Characterization of melatonin receptors and signal transduction system in rat arteries forming the circle of Willis 106
Expression of the melatonin receptors in Xenopus laevis 106
The effects of knocking out of p75NTR on the neurodegenerative phenotype in AD11 anti-NGF mice 105
Antagonization of NGF in adult mice by transgenic antibodies causes progressive learning and memory impairments 104
Development of human Nerve Growth Factor muteins with reduced algesic properties 104
METODO PER IDENTIFICARE UN INIBITORE SELETTIVO DEL PRONGF E INIBITORI SELEZIONATI CON ESSO 103
ProNGF Drives Localized and Cell Selective Parvalbumin Interneuron and Perineuronal Net Depletion in the Dentate Gyrus of Transgenic Mice 103
Memoquin, a new compound to attack Alzheimer's disease: preclinical studies 103
Non human transgenic animal as a model of neurodegenerative diseases and for the early diagnosis thereof 103
Delivery of NGF to the Brain: Intranasal Versus Ocular Administration in Anti-NGF Transgenic Mice 103
Abeta-Dependent Inhibition of LTP in Different Intra-Cortical Circuits of the Visual Cortex: The role of RAGE 102
Rat visual cortical neurones express TrkA NGF receptor 102
Rage deficiency rescues Aß-mediated inhibitory effects of different forms of long-term potentiation in mouse neocortex 102
NON HUMAN TRANSGENIC ANIMAL AS A MODEL OF NEURODEGENERATIVE DISEASES AND FOR THE EARLY DIAGNOSIS THEREOF 101
Postnatal development of astrocytes in mouse visual cortex: role of the visual experience 101
NON-HUMAN TRANSGENIC ANIMALS FOR THE STUDY OF NEURODEGENERATIVE SYNDROMES 101
Interfering with the intracellular trafficking of Aß Oligomers with conformational intrabodies 100
Memoquin: a new compound to attack Alzheimer disease on multiple fronts 100
Effects of combination treatment of galantamine and memantine on AD11 anti-NGF mice 99
NON-HUMAN TRANSGENIC ANIMALS FOR THE STUDY OF NEURODEGENERATIVE SYNDROMES 99
Memoquin, a novel multifunctional compound for Alzheimer’s disease: an up-date on preclinical studies 99
Organotypic cultures from AD11 anti-NGF transgenic mice: an in vitro model system to study neurodegeneration 99
Peripheral Neutralization of Nerve Growth Factor Induces Immunosympathectomy and Central Neurodegeneration in Transgenic Mice 99
Delivery of NGF to the brain: intranasal versus ocular administration in anti-NGF transgenic mice. J Alzheimers Dis 16: 371 99
Totale 14.863
Salva come PNG Salva come JPEG
Categoria #
all - tutte 101.325
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 101.325
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020239 0 0 0 0 0 0 0 0 0 32 195 12
2020/20212.437 195 17 501 16 185 216 76 197 209 421 128 276
2021/20221.470 141 14 11 78 99 19 31 127 92 76 71 711
2022/20236.174 413 377 260 427 382 599 4 1.562 1.850 33 124 143
2023/20241.921 268 47 215 47 137 388 72 106 209 72 10 350
2024/20256.550 1.665 292 269 738 904 180 590 335 1.265 312 0 0
Totale 22.594